IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000134 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
215,267
Total Value
$10,239,200.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 16,463 | $32.60 | $536,693.80 | 117,017 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 48,626 | $60.89 | $2,960,837.14 | 165,643 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Mar 3, 2026 | Sale | 71,600 | $79.10 | $5,663,488.40 | 94,043 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Mar 3, 2026 | Sale | 12,687 | $79.88 | $1,013,409.65 | 81,356 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Mar 3, 2026 | Sale | 802 | $80.76 | $64,771.12 | 80,554 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 16,463 | $0.00 | $0.00 | 2,406 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 48,626 | $0.00 | $0.00 | 0 | Direct | โ | View Details |